4
Changes in Ownership
Stoke Therapeutics, Inc. Filed Acc 0001966716-26-000006
GENERAL COUNSEL & CORP SEC sold 8,895 shares at an average $32.14 ($285,901)
From the SEC's structured data for this filing
Trades in this filing
Allan Jonathan · GENERAL COUNSEL & CORP SEC
Table I: Non-derivative
5 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2026-03-17 | Sale : show line 1 in the form | −2,476 | $32.74 | $81,063 | 35,255 | D |
| 2026-03-17 | Sale : show line 2 in the form | −1,791 | $33.38 | $59,775 | 33,464 | D |
| 2026-03-18 | Sale : show line 3 in the form | −4,222 | $31.28 | $132,080 | 29,242 | D |
| 2026-03-18 | Sale : show line 4 in the form | −334 | $31.79 | $10,617 | 28,908 | D |
| 2026-03-18 | Sale : show line 5 in the form | −72 | $32.85 | $2,365 | 28,836 | D |
| Open-market sales · 8,895 sh · avg $32.14 · $285,901 | ||||||
Loading xslF345X06/form4-03192026_090304.xml…